This tRF specifically interacts with nucleolin (NCL) and causes the release of p53 mRNA, promoting its translation by competing for NCL and eventually resulting in an inhibition of BC cell proliferation through this mechanism [83]. This evidence concerns the gene NUCLEOLIN and breast cancer.